| JYSZ2200045 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | License Renew | 2022-08-30 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd | | | view |
| CYSB2400204 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-08-08 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| CXSS2101070 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products(3.4) | New Drug Application | 2021-12-22 | | Shanghai Chemo Wanbang Biophama Co Ltd | | | view |
| JYSB2300072 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2023-04-26 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| CYSB2101015 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
| CXSB2300012 | 聚乙二醇重组人促红素注射液 | | Injection | Biological Products(1) | Supplementary Application | 2023-02-03 | | Shenzhen Sciprogen Bio-pharmaceutical Co Ltd | | | view |
| JYSB2200150 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2022-08-12 | | F Hoffmann-La Roche AG;Roche Pharma (Schweiz) AG | | | view |
| JYSZ2200004 | 重组人促红素-β注射液(CHO细胞) | Recombinant Human Erythropoietin β(CHO Cell) | Injection | Biological Products | License Renew | 2022-01-13 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | | | view |
| CYSB2400129 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products(3.4) | Supplementary Application | 2024-05-22 | | Shanghai Fosun Pharmaceutical Industrial Development Co Ltd;Shanghai Chemo Wanbang Biophama Co Ltd | | | view |
| CYSB2101013 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
| JXSL1000034 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2010-08-04 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2013-02-19 | view |
| JYSB2200153 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2022-08-12 | | F Hoffmann-La Roche AG;Roche Pharma (Schweiz) AG | | | view |
| JYSZ0800024 | 注射用重组人红细胞生成素 | Recombinant Human Erythropoietin(CHO Cell) | Lyophilized | Biological Products | License Renew | 2008-02-22 | | Biosidus SA | Certificate Issued | 2019-03-21 | view |
| JYSZ2200042 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | License Renew | 2022-08-30 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd | | | view |
| CYSB2400203 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-08-08 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| CYSB2101254 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-11-04 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| JXSS1300007 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2013-06-18 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | Certificate Issued | 2018-05-24 | view |
| CYSB2200264 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-11-22 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| J0401189 | 注射用重组人红细胞生成素-beta | | Lyophilized | Biological Products | License Renew | 2004-12-03 | | Shanghai Roche Pharmaceuticals Ltd Beijing | Certificate Issued | 2005-03-16 | view |
| CYSB2200100 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-03-30 | | Kexing Biopharm Co Ltd | | | view |
